Inari Medical Stock In The News

NARI Stock  USD 49.48  0.18  0.36%   
Our overall analysis of Inari Medical's news coverage and content from conventional and social sources shows investors' bearish mood towards Inari Medical. The specific impact of Inari Medical news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Inari Medical's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Inari Medical headlines in addition to utilizing other, more conventional financial analysis modules. Check out Inari Medical Backtesting and Inari Medical Hype Analysis.
For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.

Inari Medical Today Top News and Investor Outlook

Yahoo News
Analysts Estimate Inari Medical, Inc. (NARI) to Report a Decline in Earnings: What to Look Out for
https://finance.yahoo.com/news/analysts-estimate-inari-medical-inc-140021342.html
 Bullish
Yahoo News
Inari Medical Announces Partnership with AVF and NBCA on DEFIANCE Trial
https://finance.yahoo.com/news/inari-medical-announces-partnership-avf-120000089.html
 Bullish
Yahoo News
Inari Medical to Host Analyst and Investor Meeting Following PEERLESS RCT Presentation
https://finance.yahoo.com/news/inari-medical-host-analyst-investor-200600187.html
 Bullish
Yahoo News
Inari Medical to Announce Third Quarter 2024 Financial Results
https://finance.yahoo.com/news/inari-medical-announce-third-quarter-200500115.html
 Bullish
Yahoo News
Inari Medical Announces PEERLESS Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2024
https://finance.yahoo.com/news/inari-medical-announces-peerless-data-200500488.html
 Bullish
Yahoo News
FDA Classifies Recall Of Inari Medical's Large Vessel Clot Removal Catheter Device As Most Serious
https://finance.yahoo.com/news/fda-classifies-recall-inari-medicals-161746324.html
 Neutral
Yahoo News
Inari Medical (NARI) Issues Notice Post ClotTriever XL Recall
https://finance.yahoo.com/news/inari-medical-nari-issues-notice-153200447.html
 Bullish
Yahoo News
Inari Medical to Present at Upcoming Investor Conferences
https://finance.yahoo.com/news/inari-medical-present-upcoming-investor-200500629.html
 Bullish
Yahoo News
Director William Hoffman Sells 60,000 Shares of Inari Medical Inc (NARI)
https://finance.yahoo.com/news/director-william-hoffman-sells-60-230150920.html
 Neutral
Yahoo News
The Inari Medical, Inc. (NASDAQ:NARI) Second-Quarter Results Are Out And Analysts Have Published New Forecasts
https://finance.yahoo.com/news/inari-medical-inc-nasdaq-nari-122346932.html
 Bullish

Inari Medical Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Inari and other traded companies coverage with news coverage. We help investors stay connected with Inari headlines for the 25th of November to make an informed investment decision based on correlating the impacts of news items on Inari Stock performance. Please note that trading solely based on the Inari Medical hype is not for everyone as timely availability and quick action are needed to avoid losses.
Inari Medical's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Inari Medical investors visualize upcoming and past events in order to time the market based on Inari Medical noise-free hype analysis.
Inari Medical stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Inari earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Inari Medical that are available to investors today. That information is available publicly through Inari media outlets and privately through word of mouth or via Inari internal channels. However, regardless of the origin, that massive amount of Inari data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Inari Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Inari Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Inari Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Inari Medical alpha.

Inari Largest EPS Surprises

Earnings surprises can significantly impact Inari Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-02-23
2021-12-310.030.02-0.0133 
2021-08-10
2021-06-300.080.07-0.0112 
2024-04-30
2024-03-31-0.2-0.22-0.0210 
2020-08-11
2020-06-30-0.18-0.160.0211 
2022-05-04
2022-03-31-0.09-0.060.0333 
2024-10-28
2024-09-30-0.13-0.090.0430 
View All Earnings Estimates

Inari Medical Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Inari Medical Stock. Current markets are strongly bullish. About 75% of major world exchanges and indexes are currently up. See today's market update for more information.
Investing News at Macroaxis
20th of November 2024
Inari medical director William Hoffman sells 3.07m in stock
at investing.com 
Macroaxis News
18th of November 2024
Disposition of 9750 shares by William Hoffman of Inari Medical at 51.16 subject to Rule 16...
at MacroaxisInsider 
Macroaxis News
11th of November 2024
Insider Trading
at MacroaxisInsider 
Yahoo News
6th of November 2024
Inari Medical to Participate in the Jefferies London Healthcare Conference
at finance.yahoo.com 
news
1st of November 2024
Inari Medical, Inc. CEO Sells 150,000.00 in Stock
at thelincolnianonline.com 
Gurufocus Stories at Macroaxis
30th of October 2024
Inari Medical Inc Q3 2024 Earnings Revenue Hits 153M, EPS at -0. ...
at gurufocus.com 
insidermonkey News
29th of October 2024
Inari Medical, Inc. Q3 2024 Earnings Call Transcript
at insidermonkey.com 
Investing News at Macroaxis
18th of October 2024
Inari Medical director William Hoffman sells 1.8 million in stock
at investing.com 
businesswire News
17th of September 2024
Kaskela Law LLC Announces Shareholder Investigation of Inari Medical, Inc. and Encourages ...
at businesswire.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Inari Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Inari Medical's short interest history, or implied volatility extrapolated from Inari Medical options trading.
When determining whether Inari Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inari Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inari Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inari Medical Stock:
Check out Inari Medical Backtesting and Inari Medical Hype Analysis.
For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inari Medical. If investors know Inari will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inari Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.84)
Earnings Share
(1.35)
Revenue Per Share
9.901
Quarterly Revenue Growth
0.214
Return On Assets
(0.03)
The market value of Inari Medical is measured differently than its book value, which is the value of Inari that is recorded on the company's balance sheet. Investors also form their own opinion of Inari Medical's value that differs from its market value or its book value, called intrinsic value, which is Inari Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inari Medical's market value can be influenced by many factors that don't directly affect Inari Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inari Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inari Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inari Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.